NCT01630018 2016-09-22Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb TrialChong Kun Dang PharmaceuticalPhase 2 Completed141 enrolled
NCT00430144 2012-04-26Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine CervixNational Cancer Center, KoreaPhase 2 Completed16 enrolled